Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
4,359
datasets available to search
ShareScore release 0.9.0
Dataset results
4,359 results for “Insulin”
Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Insulin Glargine Alone and Lixisenatide Alone on Top of Metformin in Patients With T2DM
ClinicalTrials.gov study NCT02058147. IPD Sharing: Not stated. Countries: 23. Publications: 8.
Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma
ClinicalTrials.gov study NCT03041701. IPD Sharing: YES. Countries: 1. Publications: 1.
Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 2 Diabetes
ClinicalTrials.gov study NCT00136916. IPD Sharing: Not stated. Countries: 4. Publications: 2.
A Study Using Flash Glucose Measurements for a New Once-weekly Insulin (Insulin Icodec) in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 9)
ClinicalTrials.gov study NCT05823948. IPD Sharing: YES. Countries: 1. Publications: 1.
Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Insulin Aspart in Subjects With Type 1 Diabetes
ClinicalTrials.gov study NCT00612040. IPD Sharing: Not stated. Countries: 5. Publications: 2.
The Effect of Continuous Glucose Monitoring on Glycemic Control in Insulin-requiring Gestational Diabetes Mellitus
ClinicalTrials.gov study NCT02204657. IPD Sharing: NO. Countries: 1. Publications: 11.
Insulin Degludec and Glargine U100 for Management of Hospitalized and Discharged Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT03336528. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study of Basal Insulin Analog and Insulin Analog Mid Mixture in Chinese Participants With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT03018938. IPD Sharing: YES. Countries: 1. Publications: 1.
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
ClinicalTrials.gov study NCT02229383. IPD Sharing: Not stated. Countries: 6. Publications: 2.
Pharmacokinetics (PK)/ Pharmacodynamics (PD) of an Extended Wear Infusion Set for Continuous Subcutaneous Insulin Infusion (CSII) in Type 1 Diabetes Mellitus (T1DM) Patients ("PEXIS")
ClinicalTrials.gov study NCT04398030. IPD Sharing: NO. Countries: 1. Publications: 1.
Coin2Dose: Behavioral Economics to Promote Insulin BOLUS Activity and Improve HbA1c in Teens
ClinicalTrials.gov study NCT05280184. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT00765817. IPD Sharing: Not stated. Countries: 6. Publications: 5.
Efficacy and Safety of Linagliptin in Combination With Insulin in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00954447. IPD Sharing: Not stated. Countries: 19. Publications: 2.
Advancing Insulin Prescribing in General Practice
ClinicalTrials.gov study NCT00593489. IPD Sharing: NO. Countries: 1. Publications: 2.
A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events
ClinicalTrials.gov study NCT01959529. IPD Sharing: Not stated. Countries: 20. Publications: 15.
Effects of SomatoKine (Iplex)Recombinant Human Insulin-like Growth Factor-1/Recombinant Human Insulin-like Growth Factor-binding Protein-3 (rhIGF-I/rhIGFBP-3) in Myotonic Dystrophy Type 1 (DM1)
ClinicalTrials.gov study NCT00233519. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Empagliflozin add-on to Insulin in Type 1 Diabetes Mellitus Over 28 Days
ClinicalTrials.gov study NCT01969747. IPD Sharing: Not stated. Countries: 2. Publications: 2.
A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Glargine, in People With Type 2 Diabetes Who Have Not Used Insulin Before
ClinicalTrials.gov study NCT04460885. IPD Sharing: YES. Countries: 13. Publications: 8.
Comparison of Subject-driven Titration of Biphasic Insulin Aspart (BIAsp) 30 Twice Daily Versus Investigator-driven Titration of BIAsp 30 Twice Daily Both in Combination With Oral Antidiabetic Drugs i
ClinicalTrials.gov study NCT01618214. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Evaluation of a 4mmx32G Pen Needle for Injection of Basal Insulin Doses Above 40 Units
ClinicalTrials.gov study NCT01334606. IPD Sharing: Not stated. Countries: 2. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.